Imaging to predict liver cancer aggressiveness after surgery
Part of Cancer, Digestive system clinical trials.
This study looks at whether special scans can help doctors better predict how aggressive a person's liver cancer (hepatocellular carcinoma) will be, especially right after surgery. If you are planning to have surgery to remove the tumor as your first treatment, this trial might be a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of hepatocellular carcinoma (a specific type of liver cancer).
- You must be having surgery to remove the tumor as your first treatment.
- Your cancer must not have spread to major blood vessels, other organs, or lymph nodes.
- You must be between 18 and 80 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study uses digital scans of your tumor tissue and CT/MRI images to build a computer model that helps predict whether you might need extra treatment (adjuvant therapy) after liver cancer surgery. The goal is to use your own tissue and scan data to personalize follow-up care.
This trial uses a computer model to predict if your liver cancer might come back aggressively after surgery. If you are at high risk, you may receive additional treatment before surgery to lower that risk.
This study uses advanced imaging (ultrasound with contrast dye and MRI) combined with artificial intelligence to help doctors plan the best surgery for early-stage liver cancer. The goal is to improve treatment outcomes and help doctors choose between two surgical options: removing part of the liver or using heat to destroy the tumor.
This study uses an AI tool to predict how liver cancer might come back after surgery. It is for people with early-stage liver cancer who are already scheduled for surgery and have recent MRI scans.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
Hear when a new Hepatocellular Carcinoma Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.